Alector

Traded on the St. Petersburg Stock Exchange
Alector is a biopharmaceutical company developing drugs and treatments for neurodegenerative diseases. Alector's key products include antibodies AL001, AL101 and AL002 for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's and amyotrophic lateral sclerosis.
Alector stock price chart
vol.
change
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Alector balance sheet

Report period2018 2019 2020 2021 2022 Q2 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Alector cash flows

Report period2018 2019 2020 2021 2022 Q2 23 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Alector multipliers

Report period2018 2019 2020 2021 2022 Q2 23 TTM
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Alector profitability

Report period2018 2019 2020 2021 2022 Q2 23 TTM
ROA
ROE
ROS
EBITDA Margin
Operating margin
Alector assets
Alector cash flows

Alector dividend policy

The company doesn't provide dividends

Alector shares

TickerNameTypeNominal valueISINPrice
ALEC:USAlectorCommon share-US0144421072$5.2
Alector news
06.05.2022
Alector's GAAP loss for 3 months of 2022 was $44.617 million, down 14.5% from $52.171 million in the previous year. Revenue increased 5.9 times to $24.474 million from $4.11 million a year earlier.
Source: {source} pictogram investors.alector.com
Pictogram next
All Alector news
General information
Company nameAlector
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology
Business address131 Oyster Point Boulevard Suite 600 South San Francisco, CA 94080 United States
Mailing address131 Oyster Point Boulevard Suite 600 South San Francisco, CA 94080 United States
Websiteinvestors.alector.com
Information disclosurewww.sec.gov